The top 10 neighbors for Eli Lilly and Company span five distinct subcategories — Healthcare brands, B2B consultancies, medical journals, a government regulator, and a pharma trade publication — with scores compressed into a narrow band from 0.88 down to 0.86, the defining signature of a flat shape.
The three closest neighbors are all Healthcare brands: Bristol Myers Squibb (0.88), Deloitte Health Care (0.88), and Amgen (0.88). These are followed immediately by JAMA (0.87), a medical journal, and Tableau Software (0.87), a data analytics technology brand — the first cross-kind signal in the set. FiercePharma (0.87), a pharma trade website, and Accenture (0.87) round out the top seven, with U.S. FDA (0.86) the lone government entity in the top 10. NPR Health News (0.86) and Vertex (0.86) close the set.
Tallying subcategories across the 10: Healthcare (Bristol Myers Squibb, Amgen, Vertex — 3 neighbors), B2B (Accenture — 1), Technology (Tableau — 1), Magazines (JAMA — 1), Websites (FiercePharma — 1), Government (U.S. FDA — 1), News Publishers (NPR Health News — 1). The mix is genuinely heterogeneous: pharma peers share the top tier with a data tool, a consulting firm, a trade publication, a medical journal, and a federal regulator, all within two hundredths of a point of each other. No single subcategory dominates, and the presence of B2B and Technology neighbors alongside Healthcare ones suggests the audience is shaped as much by professional and institutional orientation as by sector identity.
The flat shape here reflects an audience that is broadly professional and analytically minded, drawn from healthcare, enterprise technology, and policy circles in roughly equal measure.